Sign in

ADDI: Recommending alternatives for drug-drug interactions with negative health effects.

Milad AllahgholiHossein RahmaniDelaram JavdaniGerhard WeissDezsö Módos
Published in: Comput. Biol. Medicine (2020)
Keyphrases
  • decision makers
  • health care
  • clinical trials
  • drug design
  • pharmaceutical industry
  • recommender systems
  • drug discovery
  • chemical compounds
  • information retrieval
  • information technology